Novo Nordisk | Stammkapital



Ordinary Share Capital Veränderung Datum
ANI Pharmaceuticals USD 2K 0 2025-03
Aurora Cannabis CAD 6.98B 907K 2024-12
Bausch Health Companies USD 369.75M 10.14B 2025-06
Bristol-Myers Squibb USD 2.04B 1.74B 2025-06
Canopy Growth CAD 8.67B 179.82M 2024-12
Corcept Therapeutics USD 105.29M 105.15M 2025-06
Drreddys Laboratories INR 834M 0 2024-12
Eli Lilly USD 946.83M 354.23M 2025-06
GlaxoSmithKline GBP 4.15B 2.8B 2025-06
Merck USD 1.79B 0 2025-03
Novartis USD 793M 0 2024-12
Novo Nordisk 4.44B 3.99B 2025-06
Novo Nordisk DKK 446M 0 2025-03
Pacira USD 44.9M 44.85M 2025-06
Perrigo USD 137.6M 6.56B 2025-06
Prestige Brands USD 49.21M 48.65M 2025-06
Sanofi 1.22B 36.5M 2025-06
Supernus Pharmaceuticals USD 56.12M 130K 2025-06
Zoetis USD 443.95M 438.95M 2025-06


Novo Nordisk Stammkapital - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Aug 2025.